Medical Week Daily Pro · Regulatory change for health startups
Wellness app or medical device? FDA's 2026 rules for wearables and clinical decision software, a founder's guide
FDA reissued two digital health guidances in January 2026 that decide whether many health startups need FDA clearance at all. This guide covers what changed, the tests FDA applies, and the claims that move a product across the line.
Published 2026-10-27 · 7 min read
This is regulatory education, not legal or regulatory advice. Guidance documents are FDA's nonbinding current thinking [2]. Confirm your product's status with qualified regulatory counsel or with FDA directly.
Why founders should care
If you build a health wearable, a symptom or sleep app, or software that helps clinicians make decisions, one question decides your budget, timeline and fundraising story: is it a medical device? If it is, you may need FDA clearance or approval before marketing it in the United States. If it is not, you can launch without one.
Keep reading with Pro
The full deep-dive, with 5 primary sources cited line by line, is for Pro members. A new deep-dive every week.
See Pro plansSources
- FDA, General Wellness Policy for Low Risk Devices, final guidance, issued 6 January 2026
- FDA, Clinical Decision Support Software, final guidance, issued 29 January 2026
- FDA, CDRH Town Hall transcript on the General Wellness update (town hall held 11 February 2026)
- FDA, Guidances with Digital Health Content (list and status)
- FDA, Digital Health Policy Navigator